Page last updated: 2024-11-02

pindolol and Pemphigus

pindolol has been researched along with Pemphigus in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Pemphigus: Group of chronic blistering diseases characterized histologically by ACANTHOLYSIS and blister formation within the EPIDERMIS.

Research Excerpts

ExcerptRelevanceReference
" In pemphigus erythematosus, very good results were obtained in 3 of 5 cases, and failure in 2 cases was probably related to insufficient dosage of steroids, or no treatment with steroids at all."1.25Visken as supplementary drug in the treatment of pemphigus. ( Blaszczyk, M; Chorzelski, T; Jablonska, S; Maciejowska, E, 1975)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chorzelski, T1
Jablonska, S1
Maciejowska, E1
Blaszczyk, M1

Other Studies

1 other study available for pindolol and Pemphigus

ArticleYear
Visken as supplementary drug in the treatment of pemphigus.
    Dermatologica, 1975, Volume: 150, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Pindolol

1975